Tumor Necrosis Factor and Human Acute Leukemia

References

• Munker R.K., Koeffler H.P. Tumor necrosis factor: recent advances. Klin Wochenscher 1989; 65: 345–352
   Web of Science ®Google Scholar
• Old L.J. Tumor necrosis factor: polypeptide mediator network. Nature 1987; 326: 330–331
   PubMed Web of Science ®Google Scholar
• Vilcek J., Palombella N.J., Swenson C, Feinman R., Hirai M., Tsujimoto M. Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J. Experta Med. 1986; 163: 632–643
   PubMed Web of Science ®Google Scholar
• Kehrl J.H., Fauci A.S. Lymphotoxin is an important T cell derived growth factor for human B cell. Science 1987; 238: 1144–1146
   PubMed Web of Science ®Google Scholar
• Munker R., Gasson J., Ogawa M., Koeffler H.P. Recombinant human TNF induces production of GM-CSF. Nature 1986; 323: 79–82
   PubMed Web of Science ®Google Scholar
• Koeffler H.P., Gasson J., Ranyard J., Snoza L., Munker R. Recombinant human TNF stimulates production of G-CSF. Blood 1987; 70: 55–59
   PubMed Web of Science ®Google Scholar
• Oster W., Linderman A., Hor S., Herrmannn F. TNF-alpha but not TNF-beta induces secretion of colony stimulating factor for macrophages (CSE-1) by human monocytes. Blood 1987; 70: 1700–1703
   PubMed Web of Science ®Google Scholar
• Nawroth P.P., Stern D.M. Modulation of endothelial cell homostatic properties by tumor necrosis factor. J. Exp. Med. 1986; 163: 1363–1375
   PubMed Web of Science ®Google Scholar
• Salem M., Delwel R., Mahmoud L.A., Clark S., Elbasousy E.M., Lowenberg B. Maturation of human acute myeloid leukemia in vitro. Br. J. Haematol. 1989; 71: 363–370
   PubMed Web of Science ®Google Scholar
• Delwel R., Salem M., Pellens C., Dorssers L., Wagemaker G., Lowenberg B. Growth regulation of human acute myeloid leukemia. Blood 1988; 72: 1944–1949
   PubMed Web of Science ®Google Scholar
• Salem M., Delwel R., Touw I., Mahmoud L.A., Elbasousy E.M., Lowenberg B. Modulation of Colony Stimulating Factor-(CSF) Dependent Growth of Acute Myeloid Leukemia by Tumor Necrosis Factor. Leukemia 1990; 4: 37–43
   PubMed Web of Science ®Google Scholar
• Murase T., Hotta T., Saito H. Predominant suppression of neutrophil colony growth by human tumor necrosis factor. Proc. Soc. Exp. Biol. Mod. 1987; 186: 188–191
   PubMed Web of Science ®Google Scholar
• Sonoda Y., Yang Y.C., Wong G.G., Clark S., Ogawa M. Analysis in serum of the targets of recombinant human hemopoietic factors. Blood 1987; 70: 185a
   Google Scholar
• Elbaz O., Budel L.M., Hoogerbrugge H., Touw I., Delwel R., Mahmoud L.A., Lowenberg B. Tumor Necrosis Factor Regulates the Expression of Granulocyte-Macrophage Colony-Stimulating Factor & lnterleukin-3 Receptors on Human Acute Myeloid Leukemia Cells. Blood 1991; 77: 989–994
   PubMed Web of Science ®Google Scholar
• Budel L.M., Elbaz O., Hoogerbrugge H., Delwel R., Mahmoud L.A., Lowenberg B., Touw I.P. Common binding structure for Granulocyte Macrophage Colony-Stimulating Factor and interleukin-3 on Human Acute Myeloid Leukemia Cells. Blood 1990; 75: 1439–1445
   PubMed Web of Science ®Google Scholar
• Elbaz O., Budel L.M., Hoogerburgge H., Touw I., Delwel R., Mahmoud L.A., Lowenberg B. Tumor Necrosis Factor Downregulates Granulocyte Colony. Stimulating Factor Receptor Expression on Human Acute Myeloid Leukemia Cells and granulocytes. J. Clin. Invest. 1991; 87: 838–841
   PubMed Web of Science ®Google Scholar
• Downing J.R., Roussel M.F., Sherr C.F. Li-gand and protein-kinase C downmodulate the colony stimulating factor-1 receptor by independent mechanisms. Mol. Cell. Biol. 1988; 9: 2890–2896
   Web of Science ®Google Scholar
• Elbaz O., Salem M., Budel L.M., Delwel R., Lowenberg B, Mahmoud L.A. TNF is a major modulator of CSF-dependent growth of human AML. Schweizerische Medizinische Wochenschrift 1991; 121: 191
   Google Scholar
• Espevik T., Brockhous M., Shalaby R. Characterization of binding of monoclonal antibodies against a human TNF receptors. J. Exp. Med. 1990; 171: 41–126
   Web of Science ®Google Scholar
• Geissler K., Trioct G., Leenhuis T., Walker E., Broxmeyer H.E. Differentiation including effects of rh-TNF in vitro on blast cells from patients with AML and myeloid blast crisis of CML. Cancer Res. 1989; 49: 3057–3062
   PubMed Web of Science ®Google Scholar
• Price G., Brenner M.K., Prentice H.G., Newland A.C. Cytotoxic effects of TNF and gamma interferon on AML blasts. Br. J. Cancer 1987; 55: 287–291
   PubMed Web of Science ®Google Scholar
• Digel W., Stefanic M., Buck C., Porzsolt F. TNF induces proliferation of neoplastic B cells from CLL. Blood 1989; 73: 1241–1245
   Web of Science ®Google Scholar
• Carswell E.A., Old L.J., Kassel R.L., Greesn S., Fiore N., Williamson B. An endotoxin-induced serum factor that causes necrosis of tumor. Proc. Natl. Acad. Sci. USA 1975; 72: 3666–3670
   PubMed Web of Science ®Google Scholar
• Elbaz O., Mahmoud L.A., Touw I., Lowenberg B. Analysis of the TNF receptors on human leukemia cells by affinity cross linking. Br. J. Haematol. 1992; 81: 530–532
   PubMed Web of Science ®Google Scholar
• Tobler A., Munker R., Heitjam D., Koeffler H.P. In vitro interaction of TNF and all-trans-retonoic acid with normal and leukemic hematopoietic cells. Blood 1987; 70: 1940–1946
   PubMed Web of Science ®Google Scholar
• Hirano K., Yammamoto K., Kobayashi Y., Ogawa T. Characterization of specific high affinity receptors for human lymphotoxin. J. Biochem. 1989; 105: 120–126
   PubMed Web of Science ®Google Scholar
• Larrick J.W., Graham D., Toy K., Lin L. Recombinant TNF causes activation of human granulocytes. Blood 1987; 69: 640–644
   PubMed Web of Science ®Google Scholar
• Girardin E., Grau G.E., Dayer J.M., Lambert P.H. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. New Engl. J. Med. 1988; 319: 397
   PubMed Web of Science ®Google Scholar
• Spactofara M., Merendino A., Chiappara G. Lung compartementalization of increased TNF releasing ability by mononuclear phagocytes in sarcoidosis. Chest 1989; 96: 542
   PubMed Web of Science ®Google Scholar
• Scuderi P., Lam K.S., Ryon K.J. Raised serum levels of tumor necrosis factor in parasitic infections. Lancet 1989; ii: 1364
   Google Scholar
• Lahderirta J., Maury C.P.J., Teppo A.M., Repo H. Elevated levels of circulating TNF in patients with acquired immunodeficiency syndrome. Am. J. Med. 1988; 85: 289
   PubMed Web of Science ®Google Scholar
• Balkwill F.R., Lee A., Aldam G., Fiers W. Human Tumor xenografts treated with recombinant human tumor necrosis factor. Cancer Res. 1986; 46: 3990–3993
   PubMed Web of Science ®Google Scholar
• Mayer R.J. Allogenic Transplantation versus intensive chemotherapy in first remission acute leukemia: is there a “best choice”. J. Clin. Oncol. 1988; 6: 1532–1536
   PubMed Web of Science ®Google Scholar
• Lowenberg B., Zittoun R., Kerhofs H. On the value of intensive remission induction chemotherapy in elderly patients with acute myeloid leukemia. J. Clin. Oncol. 1989; 1: 1268–1274
   Google Scholar
• Chauaib S., Bertoglio J., Blay J.Y., Marchiol C., Fradelizi D. Generation of lymphokirie-activated killer cells: synergy between tumor necrosis factor and interleukin-2. Proc. Natl. Acad. Sci. 1988; 85: 6875–6880
   PubMed Web of Science ®Google Scholar
• Yang S.C., Owen-Shaub L., Grimm E.A., Roth J.A. Induction of lymphokine-activated killer cytotoxicity with IL-2 and TNF-alpha against primarily lung targets. Cancer Immunol. Immunotherapy 1989; 29: 193–198
   PubMed Web of Science ®Google Scholar
• Nakano K., Okugawa K., Furuichi H., Matsui Y., Sohmura Y. Augmentation of the generation of cytotoxic T lymphocytes against tumor cells by recombinant human tumor necrosis factor. Cell Immunol. 1989; 120: 154–159
   PubMed Web of Science ®Google Scholar
• Paul W.E. Pleiotropy and redundancy: T cell-derived lymphokinase in the immune response. Cell 1989; 57: 512–514
   Web of Science ®Google Scholar